These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30923318)

  • 1. Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy.
    El-Jawahri A; Abel GA; Traeger L; Waldman L; Markovitz N; VanDusen H; Fathi A; Steensma DP; LeBlanc TW; Horick NK; DeAngelo DJ; Wadleigh M; Hobbs G; Foster J; Brunner AM; Amrein P; Stone RM; Temel JS; Greer JA
    Leukemia; 2019 Oct; 33(10):2393-2402. PubMed ID: 30923318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial.
    El-Jawahri A; LeBlanc TW; Kavanaugh A; Webb JA; Jackson VA; Campbell TC; O'Connor N; Luger SM; Gafford E; Gustin J; Bhatnagar B; Walker AR; Fathi AT; Brunner AM; Hobbs GS; Nicholson S; Davis D; Addis H; Vaughn D; Horick N; Greer JA; Temel JS
    JAMA Oncol; 2021 Feb; 7(2):238-245. PubMed ID: 33331857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial.
    El-Jawahri A; Luskin MR; Greer JA; Traeger L; Lavoie M; Vaughn DM; Andrews S; Yang D; Boateng KY; Newcomb RA; Ufere NN; Fathi AT; Hobbs G; Brunner A; Abel GA; Stone RM; DeAngelo DJ; Wadleigh M; Temel JS
    Cancer; 2023 Apr; 129(7):1075-1084. PubMed ID: 36655338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience.
    Vachhani P; Al Yacoub R; Miller A; Zhang F; Cronin TL; Ontiveros EP; Thompson JE; Griffiths EA; Wang ES
    Leuk Res; 2018 Dec; 75():29-35. PubMed ID: 30445237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia.
    El-Jawahri A; Nelson-Lowe M; VanDusen H; Traeger L; Abel GA; Greer JA; Fathi A; Steensma DP; LeBlanc TW; Li Z; DeAngelo D; Wadleigh M; Hobbs G; Foster J; Brunner A; Amrein P; Stone RM; Temel JS
    Oncologist; 2019 Feb; 24(2):247-254. PubMed ID: 30139841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial.
    Nelson AM; Amonoo HL; Kavanaugh AR; Webb JA; Jackson VA; Rice J; Lavoie MW; Fathi AT; Brunner AM; Greer JA; Temel JS; El-Jawahri A; LeBlanc TW
    Cancer; 2021 Dec; 127(24):4702-4710. PubMed ID: 34460937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age.
    Alibhai SM; Breunis H; Timilshina N; Brignardello-Petersen R; Tomlinson G; Mohamedali H; Gupta V; Minden MD; Li M; Buckstein R; Brandwein JM
    J Geriatr Oncol; 2015 Jul; 6(4):262-71. PubMed ID: 25944029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach.
    Boddu PC; Kantarjian HM; Ravandi F; Garcia-Manero G; Verstovsek S; Jabbour EJ; Takahashi K; Bhalla K; Konopleva M; DiNardo CD; Ohanian M; Pemmaraju N; Jain N; Pierce S; Wierda WG; Cortes JE; Kadia TM
    Cancer; 2017 Aug; 123(16):3050-3060. PubMed ID: 28387922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Longitudinal Coping Strategies and Outcomes in Patients With Acute Myeloid Leukemia.
    Amonoo HL; Daskalakis E; Deary EC; Bodd MH; Reynolds MJ; Nelson AM; Newcomb R; Dhawale TM; Yang D; Luger SM; Gustin JL; Brunner A; Fathi AT; LeBlanc TW; El-Jawahri A
    J Natl Compr Canc Netw; 2022 Oct; 20(10):1116-1123. PubMed ID: 36240844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coping strategies in patients with acute myeloid leukemia.
    Amonoo HL; Bodd MH; Reynolds MJ; Nelson AM; Newcomb R; Johnson PC; Dhawale TM; Plotke R; Heuer L; Gillani S; Yang D; Deary EC; Daskalakis E; Goldschen L; Brunner A; Fathi AT; LeBlanc TW; El-Jawahri A
    Blood Adv; 2022 Apr; 6(7):2435-2442. PubMed ID: 34768282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.
    Tran H; Yang D
    Ann Pharmacother; 2012 Jan; 46(1):89-96. PubMed ID: 22170975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms, Mobility and Function, and Quality of Life in Adults With Acute Leukemia During Initial Hospitalization.
    Leak Bryant A; Gosselin TG; Coffman EM; Phillips B; Gray TF; Knafl GJ; Klepin HD; Wood WA; Muss H; Reeve BB
    Oncol Nurs Forum; 2018 Sep; 45(5):653-664. PubMed ID: 30118443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML.
    Cortes JE; Lin TL; Uy GL; Ryan RJ; Faderl S; Lancet JE
    J Hematol Oncol; 2021 Jul; 14(1):110. PubMed ID: 34256819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-intensity chemotherapy versus palliative chemotherapy in patients over 60 years with acute myeloid leukemia].
    Medrano-Contreras J; Talavera-Piña JO; Guerrero-Rivera S; Gutiérrez-Espíndola GR; Gómez-Cortés C; Pérez-Rocha JF; Terreros-Muñoz E; Meillón-García LA
    Rev Med Inst Mex Seguro Soc; 2016; 54 Suppl 2():S148-55. PubMed ID: 27561018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do quality of life or physical function at diagnosis predict short-term outcomes during intensive chemotherapy in AML?
    Timilshina N; Breunis H; Brandwein JM; Minden MD; Gupta V; O'Neill S; Tomlinson GA; Buckstein R; Li M; Alibhai SMH
    Ann Oncol; 2014 Apr; 25(4):883-888. PubMed ID: 24667720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Intensive Chemotherapy on Physical, Cognitive, and Emotional Health of Older Adults with Acute Myeloid Leukemia.
    Klepin HD; Tooze JA; Pardee TS; Ellis LR; Berenzon D; Mihalko SL; Danhauer SC; Rao AV; Wildes TM; Williamson JD; Powell BL; Kritchevsky SB
    J Am Geriatr Soc; 2016 Oct; 64(10):1988-1995. PubMed ID: 27627675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old.
    Gupta N; Miller A; Gandhi S; Ford LA; Vigil CE; Griffiths EA; Thompson JE; Wetzler M; Wang ES
    Am J Hematol; 2015 Jul; 90(7):639-46. PubMed ID: 25808347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of an embedded primary care-derived electronic health record (EHR) frailty index (eFI) in older adults with acute myeloid leukemia.
    Cheng JJ; Tooze JA; Callahan KE; Pajewski NM; Pardee TS; Reed DR; Klepin HD
    J Geriatr Oncol; 2023 Sep; 14(7):101509. PubMed ID: 37454532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.
    Seymour JF; Döhner H; Butrym A; Wierzbowska A; Selleslag D; Jang JH; Kumar R; Cavenagh J; Schuh AC; Candoni A; Récher C; Sandhu I; Del Castillo TB; Al-Ali HK; Falantes J; Stone RM; Minden MD; Weaver J; Songer S; Beach CL; Dombret H
    BMC Cancer; 2017 Dec; 17(1):852. PubMed ID: 29241450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
    DiNardo CD; Maiti A; Rausch CR; Pemmaraju N; Naqvi K; Daver NG; Kadia TM; Borthakur G; Ohanian M; Alvarado Y; Issa GC; Montalban-Bravo G; Short NJ; Yilmaz M; Bose P; Jabbour EJ; Takahashi K; Burger JA; Garcia-Manero G; Jain N; Kornblau SM; Thompson PA; Estrov Z; Masarova L; Sasaki K; Verstovsek S; Ferrajoli A; Weirda WG; Wang SA; Konoplev S; Chen Z; Pierce SA; Ning J; Qiao W; Ravandi F; Andreeff M; Welch JS; Kantarjian HM; Konopleva MY
    Lancet Haematol; 2020 Oct; 7(10):e724-e736. PubMed ID: 32896301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.